Live
- BJP releases ‘charge sheet’ against BJD govt
- District Nodal Officer Venkataramana announced the intermediate results
- She team that stopped child marriages
- Medical devices sector needs separate rules, says industry body AiMeD
- Andhra Paper declares lockout
- Opposition INDIA bloc working on 'one year, one PM' formula: PM Modi
- Delhi HC quashes FIR for outraging woman's modesty, orders man to assist Traffic Police for a month as settlement
- 'Apologise to families of farmers who committed suicide in Vidarbha', Amit Shah dares Sharad Pawar
- SC Collegium recommends appointment of a permanent judge in Chhattisgarh HC, extension of term of two judges
- U20 Men's football nationals: Telangana, Sikkim earn full points with easy win
PM Narendra Modi reviews preparations for vaccination against Covid-19
Prime Minister Narendra Modi on Tuesday chaired a high-level meeting to review the preparations being undertaken for vaccination against Covid-19, as and when a vaccine is available.
NEW DELHI: Prime Minister Narendra Modi on Tuesday chaired a high-level meeting to review the preparations being undertaken for vaccination against Covid-19, as and when a vaccine is available.
The Prime Minister directed officials to evaluate various technology tools to ensure efficient and timely vaccination in due course of time.
He also emphasised that detailed planning for such large scale vaccination should be undertaken immediately.
The current status of Indian and global vaccine development efforts was also reviewed at the meeting.
The Prime Minister highlighted that India's responsibility and commitment to the global community to play an enabling role in global vaccination efforts against Covid-19.
PM-CARES (Prime Minister's Citizen Assistance and Relief in Emergency Situations) Fund Trust had earlier allocated Rs 100 crore for coronavirus vaccine development.
India's coronavirus count has reached 5,66,840 including 16,893 deaths, according to the Union Health and Family Welfare Ministry on Tuesday.
Earlier, Hyderabad-based Bharat Biotech announced that it has successfully developed Covaxin, India's first vaccine candidate for Covid-19, in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).
The Drug Controller General of India - CDSCO, Ministry of Health & Family Welfare granted permission to initiate Phase I & II Human clinical trials after the company submitted results generated from preclinical studies, demonstrating safety and immune response.
Human clinical trials are scheduled to start across India in July 2020. The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech.
